NETTER-1 phase III in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate : Efficacy, safety, QoL results and subgroup analysis

Strosberg, J. (author)

Univ S Florida, H Lee Moffitt Canc Ctr, Oncol, Tampa, FL USA.

Wolin, E. (author)

Univ Kentucky, Oncol, Lexington, KY USA.

Chasen, B. (author)

Univ Texas Hlth Sci Ctr Houston, Nucl Med, Houston, TX 77030 USA.

show more...

Kulke, M. (author)

Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA.

Bushnell, D. (author)

Univ Iowa, Div Nucl Med, Iowa City, IA USA.

Caplin, M. (author)

Royal Free Hosp, Sch Med, Neuroendocrine Tumour Unit, Gastroenterol, London, England.

Baum, R. (author)

Zent Klin Bad Berka GmbH, Nucl Med, Bad Berka, Germany.

Kunz, P. L. (author)

Stanford Univ, Med Ctr, Oncol, Stanford, CA 94305 USA.

Hobday, T. (author)

Mayo Clin, Oncol, Rochester, NY USA.

Hendifar, A. (author)

Cedars Sinai Med Ctr, Oncol, Los Angeles, CA 90048 USA.

Öberg, Kjell E., 1946- (author)

Uppsala universitet,Endokrin tumörbiologi

Sierra, M. Lopera (author)

Adv Accelerator Applicat, New York, NY USA.

Kwekkeboom, D. (author)

Erasmus Univ, Med Ctr, Nucl Med Dept, Rotterdam, Netherlands.

Ruszniewski, P. (author)

Hop Beaujon, Gastroenterol, Clichy, France.

Krenning, E. (author)

Erasmus Univ, Med Ctr, Oncol, Rotterdam, Netherlands.

show less...

Univ S Florida, H Lee Moffitt Canc Ctr, Oncol, Tampa, FL USA Univ Kentucky, Oncol, Lexington, KY USA. (creator_code:org_t)

2016

2016

English.

In: Annals of Oncology. - 0923-7534 .- 1569-8041. ; 27:6

Related links:

https://urn.kb.se/re...

• Journal article (peer-reviewed)